Pseudomonas aeruginosa phage lysate as an immunobiological agent 1. Selection of Pseudomonas aeruginosa clinical strains for phage lysate preparation

Folia Microbiologica

Volumn 44, Issue 1, 1999, Pages 93-97

  Sekaninova G ^a   Kolarova M ^a   Pillich, J ^b   Semenka J ^a   Slavikova H ^b   Kubickova D ^a   Zajicova V ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

BACTERIAL ANTIGEN;

ARTICLE; BACTERIOPHAGE TYPING; CLASSIFICATION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE; VIROLOGY;

ANTIGENS, BACTERIAL; BACTERIOPHAGE TYPING; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGES;

EID: 0032609567     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02816229     Document Type: Article

References (37)

1. ADAMS M.H.: Bacteriophages. Interscience Publishers, New York 1959.
2. AESHESHOV E.H.: An assessment of the methods used for typing strains of Pseudomonas aeruginosa, in Proc. 6th Nat. Congr. Bacteriology. Leontiadi Medical Editions, Athens 1974.
3. BERGOGNE-BÉRÉZIN E., DECRÉ D., JOLY-GUILLOU M.-L.: Opportunistic nosocomial resistant bacterial infections -their treatment and prevention. J.Antimicrob.Chemother. 32, 39-47 (1993).
4. CRYZ S.J.: Pseudomonas aeruginosa infections, in Bacterial Vaccines. R. Germanier Edition. Academic Press, London-New York 1984.
5. CRYZ S.J., SANDORFF J.C., FURER E.: Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Microb. Pathogen. 6, 75-80 (1989).
6. EKO F.O., HENSEL A., BUNKA S., LUBITZ W.: Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunisation of mice. Vaccine 12, 1330-1334 (1994).
7. FELDMAN M., BRYAN R., RAJAN S., SCHEFFLER L., BRUNNERT S., TANG H., PRINCE A.: Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect.Immun. 66, 43-51 (1998).
8. FICHTENBAUM C.J., WOELTJE K.F., POWDERLY W.G.: Serious Pseudomonas aeruginosa infections in patients infected with Human Immmunodeficiency Virus: case-control study. Clin.Infect.Dis. 19, 417-422 (1994).
9. FRASCH C.E.: Serogroup and serotype classification of bacterial pathogens. Methods Enzymol. 235, 159-174 (1994).
10. GATELL J.M., TRILLA A., LATORRE X., ALMELA M., MENSA J., MORENO A., MIRO J.M., MARTINEZ JA., JIMENEZ DE ANTA M.T., SORIANO E., GARCIA SAN MIGUEL J.: Nosocomial bacteremia in a large Spanish Teaching Hospital: analysis of factors influencing prognosis. Rev.Infect.Dis. 10, 203-209 (1988).
11. HEUKESHOVEN I., DERNICK R.: Improved silver staining procedure for fast staining in Pfast System Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 9, 28-32 (1988).
12. HOLDER I.A., WHEELER R., MONTIE T.C.: Flagelar preparations from Pseudomonas aeruginosa: animal protection studies. Infect.Immun. 35, 276-280 (1982).
13. HOLDER I.A., VOLPEL K., RONALD G., PARANCHYCH W.: Studies on multiple Pseudomonas aeruginosa isolates from individual burn patients by RFLP, O antigen serotyping and antibiogram analysis. Burns 21, 441-444 (1995).
14. JAEGER K.-E., RANSAC S., DUSKSTRA B.W., COLSON C., VAN HEUVEL M., MISSET O.: Bacterial lipases. FEMS MicrobioLRev. 15, 29-63 (1994).
15. JARVIS W.R., MARTONE W.J.: Predominant pathogens in hospital infections. J.Antimicrob.Chemother. 29, 19-24 (1992).
16. KAHLICH R., LOMOVÁ J., TÁBORSKÝ J., SEDLÁČKOVÁ E., LIŠKA M., PECHANCOVÁ J., TOTUŠEK P., VÝMOLA F., ŠOUREK J.: Pre-operative use of the PSAEVA Pseudomonas vaccine in cardiac surgery. Cor Vasa 37, 26-33 (1995).
17. LAEMMLI U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970).
18. LIEBERMAN M.M., WALKER H.L., AYALA E., CHAPA I.: Active and passive immunisation with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model. J.Surg.Res. 40, 138-144 (1986).
19. MAY T.B., SHINABARGER D., MAHARAJ R., KATO J., CHU L., DEVAULT J.D., ROYCHOUDHURY S., ZIELINSKI N.A., BERRY A., ROTHMEL R.K., MISRA T.K., CHAKRABARTY A.M.: Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin.Microbiol.Rev. 4, 191-206 (1991).
20. MILER J.M., SPILSBURY R.F., JONES R.J., ROE E.A., LOWBURY E.J.L.: A new polyvalent Pseudomonas vaccine. J.Med.Microbiol. 10, 19-27 (1977).
21. MUTHARIA L.M., NICAS T.I., HANCOCK R.E.W.: Outer membranes of Pseudomonas aeruginosa serotype strains. J.Infect.Dis. 146, 770-779 (1982).
22. NEU H.C.: The crisis in antibiotic resistance. Science 257, 1064-1073 (1992).
23. NISHIO M., YUTAKA I., HIROSHI H., SHIGEAKI O., KENJI O., NORIHISA I.: The genetic effect of engineered vaccine on Pseudomonas aeruginosa infection in mice. Immunogenetics 38, 280-282 (1993).
24. NOONE M.R., PITT T.L., BEDER M., HEWLETT A.M., ROGERS K.B.: Pseudomonas aeruginosa colonisation in an intensive therapy unit: role of cross infection and host factors. Brit.Med.J. 286, 341-344 (1983).
25. PENNINGTON J.E.: Lipopolysaccharide Pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa. J.Infect.Dis. 140, 73-80 (1979).
26. PIER G.B.: Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa. J.Clin.Invest. 69, 303-308 (1982).
27. PILLICH J., KUBÍČKOVÁ D., VÝMOLA F.: Phage plaques and autoplaques in Pseudomonas aeruginosa strain. J.Hyg.Epidem. 28, 163-167 (1985).
28. PILLICH J., VÝMOLA F.: Polyvalent staphytococcal vaccine for injection or topical (i.e. instillation) administration. (In Czech) Czech.Pat. 203 718 (1983).
29. SCHIMPFF S.: Gram-negative bacteremia. Support. Care Cancer 5-18 (1993).
30. SENSAKOVIC J.W., BARTELL P.F.: Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice. Infect.Immun. 18, 304-309 (1977).
31. SHOOTER R.A., WALKER K.A., WILLIAMS V.R., MORGAN G.M., PARKER M.T., ASHESHOV E.H., BULLIMORE J.F.: Fæcal carriage of Pseudomonas aeruginosa in hospital patients. Lancet 1331-1334 (1966).
32. SILVER D.R., COHEN I.L., WEINBERG P.F.: Recurrent Pseudomonas aeruginosa pneumonia in an Intensive Care Unit. CHEST 101, 194-198 (1992).
33. SLAVÍKOVÁ H., RYŠÁNKOVÁ J., PILLICH J., VONDRÁČEK J.: Bacterial lysate STAVA in prevention and therapy of chronic respiratory tract infections. Proc. Internat. Conf. Experimental, Therapeutic and Toxic Manipulations of Host Defence System. Purkyně Military Medical Academy, Hradec Králové (Czech Republic) 1995.
34. ŠOUREK J., VÝMOLA F., ZELENKOVÁ L.: Mouse protection experience with monovalent Pseudomonas aeruginosa vaccine. Zbl. Bakt.Hyg.I Abt.Orig.A 246, 353-362 (1980).
35. STANISLAVSKY E.S., LAM J.S.: Pseudomonas aeruginosa antigens as potential vaccines. FEMS Microbiol.Rev. 21, 243-277 (1997).
36. STODDART J.C., AIREY I.L., AL-JUMAILI I.J., BINT A.J.: Pseudomonas aeruginosa in the Intensive Care Unit. Intensive Care Med. 279-282 (1982).
37. TOTH A., SCHÖDEL F., DUCHÉNE M., MASSARRAT K., BLUM B., SCHMITT A., DOMDEY H., VON SPECHT B.-U.: Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin. Vaccine 12, 1215-1221 (1994).